Close Menu

iPS Academia Japan

NEW YORK (GenomeWeb News) – Life Technologies today announced a worldwide, non-exclusive deal with iPS Academia Japan for its induced pluripotent stem cell patent portfolio.

NEW YORK (GenomeWeb News) – Cellular Dynamics today announced it has expanded its distribution deal with iPS Academia Japan to include iCell Neurons and iCell Endothelial Cells.

NEW YORK (GenomeWeb News) – Sigma-Aldrich today said that it has licensed worldwide rights to Kyoto University's induced pluripotent stem cell patent portfolio.

iPS Academia Japan will distribute the firm's iCell Cardiomyocytes in Japan.

The French firm licensed non-exclusive rights to certain patents covering research conducted by Shinya Yamanaka of the Center for iPS Cell Research and Application at Kyoto University in Japan.

Cellular Dynamics and iPS Academia Japan announced a non-exclusive licensing agreement giving CDI access to an induced pluripotent stem cell portfolio based on research done by Kyoto University researcher Shinya Yamanaka.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.